Igm Biosciences, Inc.
IGMS
Revenue
0.00
0.000.00%
-Assets
265.71M
▼-38.80M▼-12.74%
3 Months ChangeLiabilities
217.54M
▼-8.02M▼-3.56%
3 Months ChangeFree Cash Flow
-44.90M
▲10.03M▲18.26%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-03
Form 8-K
ID: 0001193125-24-232252
2024-08-14
Form 8-K
ID: 0000950170-24-096641
2024-08-14
Form 10-Q
ID: 0000950170-24-096639
2024-07-05
Form 8-K
ID: 0000950170-24-081867
2024-06-14
Form 8-K
ID: 0000950170-24-073354
2024-05-08
Form 8-K
ID: 0000950170-24-055654
2024-05-08
Form 10-Q
ID: 0000950170-24-055615
2024-04-17
Form 8-K
ID: 0000950170-24-044931
2024-03-07
Form 8-K
ID: 0000950170-24-027952
2024-01-08
Form 8-K
ID: 0000950170-24-002737